COM:RUBIUSTX
Rubius Therapeutics
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
rubiustx.comcrunchbase
rubius-therapeuticslinkedin
rubius-therapeuticsfounding date
Jan 01, 2013ipo date
Jul 18, 2018
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX...Show More